Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver D Howes

Showing results (141-150 of 329) with videos related to

Pageof 33
Sort By:
Neuroimage. Clinical|November 4, 2025
Emotion processing in schizophrenia and its relation to μ-opioid receptor availabilityEkaterina Shatalina, Abhishekh H Ashok, Matthew B Wall, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 29, 2014
Prevalence of serum N-methyl-D-aspartate receptor autoantibodies in refractory psychosisKatherine Beck, John Lally, Sukhwinder S Shergill, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 7, 2022
Reappraising the variability of effects of antipsychotic medication in schizophrenia: a meta-analysisRobert A McCutcheon, Toby Pillinger, Orestis Efthimiou, et al.
Schizophrenia Research|September 17, 2022
Efficacy and safety of Lu AF35700 in treatment-resistant schizophrenia: A randomized, active-controlled trial with open-label extensionJohn M Kane, Bruce J Kinon, Carlos Forray, et al.
Journal of Clinical Psychopharmacology|May 7, 2005
Bone mineral density and its relationship to prolactin levels in patients taking antipsychotic treatmentOliver D Howes, Michael J Wheeler, Anna-Maria Meaney, et al.
The American Journal of Psychiatry|December 20, 2015
Resting Hyperperfusion of the Hippocampus, Midbrain, and Basal Ganglia in People at High Risk for PsychosisPaul Allen, Christopher A Chaddock, Alice Egerton, et al.
Human Psychopharmacology|December 7, 2017
Higher serotonin transporter availability in early-onset obsessive-compulsive disorder patients undergoing escitalopram treatment: A [<sup>11</sup> C]DASB PET studyJunhee Lee, Bo-Hyung Kim, Euitae Kim, et al.
Schizophrenia Research|October 14, 2008
Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imagingSubrata K Bose, Federico E Turkheimer, Oliver D Howes, et al.
The American Journal of Psychiatry|July 20, 2011
Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging studyOliver D Howes, Subrata K Bose, Federico Turkheimer, et al.
Journal of Psychopharmacology (Oxford, England)|May 12, 2023
Low-frequency monitoring for community clozapine initiations: A comparative study relative to standard frequency assessmentsYuya Mizuno, Devi L Bridglal, Jack Coumbe, et al.
Pageof 33

Showing results (141-150 of 329) with videos related to

Sort By:
Pageof 33
Neuroimage. Clinical|November 4, 2025
Emotion processing in schizophrenia and its relation to μ-opioid receptor availabilityEkaterina Shatalina, Abhishekh H Ashok, Matthew B Wall, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 29, 2014
Prevalence of serum N-methyl-D-aspartate receptor autoantibodies in refractory psychosisKatherine Beck, John Lally, Sukhwinder S Shergill, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 7, 2022
Reappraising the variability of effects of antipsychotic medication in schizophrenia: a meta-analysisRobert A McCutcheon, Toby Pillinger, Orestis Efthimiou, et al.
Schizophrenia Research|September 17, 2022
Efficacy and safety of Lu AF35700 in treatment-resistant schizophrenia: A randomized, active-controlled trial with open-label extensionJohn M Kane, Bruce J Kinon, Carlos Forray, et al.
Journal of Clinical Psychopharmacology|May 7, 2005
Bone mineral density and its relationship to prolactin levels in patients taking antipsychotic treatmentOliver D Howes, Michael J Wheeler, Anna-Maria Meaney, et al.
The American Journal of Psychiatry|December 20, 2015
Resting Hyperperfusion of the Hippocampus, Midbrain, and Basal Ganglia in People at High Risk for PsychosisPaul Allen, Christopher A Chaddock, Alice Egerton, et al.
Human Psychopharmacology|December 7, 2017
Higher serotonin transporter availability in early-onset obsessive-compulsive disorder patients undergoing escitalopram treatment: A [<sup>11</sup> C]DASB PET studyJunhee Lee, Bo-Hyung Kim, Euitae Kim, et al.
Schizophrenia Research|October 14, 2008
Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imagingSubrata K Bose, Federico E Turkheimer, Oliver D Howes, et al.
The American Journal of Psychiatry|July 20, 2011
Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging studyOliver D Howes, Subrata K Bose, Federico Turkheimer, et al.
Journal of Psychopharmacology (Oxford, England)|May 12, 2023
Low-frequency monitoring for community clozapine initiations: A comparative study relative to standard frequency assessmentsYuya Mizuno, Devi L Bridglal, Jack Coumbe, et al.
Pageof 33